News and Press - JDRF T1D Fund

Recent Press Releases

T1D Fund in the News

RA Capital, OrbiMed join autoimmune disorder biotech’s $80M round

April 02, 2020 | Boston Business Journal

T1D Fund in the News

Pandion Therapeutics scores $80M to drive autoimmune programs through clinic

April 01, 2020 | FierceBiotech

Pandion Therapeutics Announces Close of $80 Million Series B Financing

April 01, 2020 | CAMBRIDGE, Mass.

Repertoire Immune Medicines Launches Type 1 Diabetes Focused Program with Investment from JDRF T1D Fund

March 25, 2020 | CAMBRIDGE, Mass. & BOSTON

Immunocore Secures $130 Million Series B Financing

March 02, 2020 | Oxfordshire, UK and Conshohocken, Pa. and Rockville, Md.